All clinical conditions

Clinical condition

Health Anxiety (Illness Anxiety Disorder)

DSM-5-TR 300.7 (F45.21) / ICD-11 6B23

Illness anxiety disorder — preoccupation with having or acquiring a serious illness despite minimal or absent somatic symptoms and reassuring medical evaluation. Formerly hypochondriasis. CBT and SSRIs are first-line. Distinct from somatic symptom disorder and OCD.

Common ways people search for this

Health anxiety treatmentIllness anxiety disorderHypochondria treatmentConvinced I have a serious illnessFear of being sick all the time
The short version
  • Illness anxiety disorder (IAD), the DSM-5-TR successor to most of what was called hypochondriasis, is a preoccupation with having or acquiring a serious illness in which somatic symptoms are absent or only mild — the distress is driven by the fear and the misinterpretation of bodily sensations, not by the symptoms themselves.
  • It is characterized by a high level of health anxiety, disproportionate alarm about personal health status, and either excessive health-related behaviors (repeated body checking, doctor-shopping) or maladaptive avoidance (refusing appointments, avoiding hospitals).
  • DSM-5-TR split the old hypochondriasis category: patients with prominent somatic symptoms now map to somatic symptom disorder, while those with minimal symptoms and predominant illness fear map to illness anxiety disorder.
  • First-line treatment is cognitive-behavioral therapy specifically adapted for health anxiety, with strong randomized-trial evidence including internet-delivered formats; SSRIs are also effective and first-line, with the best controlled evidence from the medication-and-CBT trial by Fallon and colleagues.
  • Repeated reassurance-seeking and excessive medical testing paradoxically maintain the disorder — they relieve anxiety briefly but reinforce the checking cycle, so treatment deliberately reduces reassurance behaviors.
  • Ketamine is not a treatment for illness anxiety disorder. It is relevant only when a co-occurring treatment-resistant major depression is present; the health anxiety itself is treated with CBT and SSRIs.

Clinical definition

DSM-5-TR illness anxiety disorder requires: (1) preoccupation with having or acquiring a serious illness; (2) somatic symptoms are not present or, if present, only mild — and if another medical condition exists or there is high risk of one, the preoccupation is clearly excessive or disproportionate; (3) a high level of anxiety about health and an easily alarmed personal health status; (4) excessive health-related behaviors (e.g., repeatedly checking the body for signs of illness) or maladaptive avoidance (e.g., avoiding doctor appointments and hospitals); (5) illness preoccupation present for at least 6 months, though the specific feared illness may change; (6) not better explained by another mental disorder. DSM-5-TR specifies a care-seeking type and a care-avoidant type. This category, together with somatic symptom disorder, replaced DSM-IV hypochondriasis: roughly three-quarters of former hypochondriasis patients (those with significant somatic symptoms) are recategorized as somatic symptom disorder, and the remainder (minimal somatic symptoms, predominant illness fear) as illness anxiety disorder. ICD-11 codes hypochondriasis under 6B23 within obsessive-compulsive and related disorders, reflecting the phenomenologic overlap with OCD — a notable taxonomic difference from DSM-5-TR, which places it among somatic symptom and related disorders. Epidemiologically, health anxiety is common in medical settings, frequently comorbid with depression and other anxiety disorders, and a substantial driver of healthcare utilization.

How it differs from related conditions

vs. Somatic symptom disorder (SSD)

SSD centers on distressing SOMATIC symptoms that are actually present (pain, fatigue, GI symptoms) plus excessive thoughts/behaviors about them. Illness anxiety disorder centers on the FEAR of illness with minimal or no somatic symptoms. The presence and prominence of actual bodily symptoms is the dividing line. The two replaced DSM-IV hypochondriasis between them.

vs. Obsessive-compulsive disorder (OCD)

OCD involves intrusive obsessions and compulsions across varied themes; the compulsions (checking, reassurance) are ego-dystonic and recognized as excessive. Health anxiety can resemble OCD (body-checking as a compulsion), and ICD-11 actually groups hypochondriasis with OCD. The distinction in practice: in IAD the content is exclusively illness-focused and the belief is often less clearly recognized as irrational. Substantial overlap; some patients meet both.

vs. Generalized anxiety disorder (GAD)

GAD worry spans many domains (finances, work, relationships, health); illness anxiety disorder worry is specifically and persistently about having or getting a serious disease. If health is just one of many worry domains, GAD is the better fit. Both can co-occur.

vs. Panic disorder

Panic disorder patients fear the acute catastrophe of an attack (heart attack, dying) in the moment; IAD patients have a sustained, between-episode preoccupation with having an underlying disease. The time course differs — acute discrete fear versus chronic preoccupation. Patients with panic may develop secondary health anxiety about what the attacks mean.

First-line treatments

Cognitive-behavioral therapy for health anxiety (CBT-HA)

First-line and best-evidenced treatment. CBT for health anxiety targets catastrophic misinterpretation of benign bodily sensations, the reassurance-seeking and body-checking cycle, and the selective attention to health threat. Treatment deliberately reduces reassurance-seeking (which maintains the disorder) and uses behavioral experiments and exposure to health-related triggers. Effect sizes are robust in randomized trials; gains are durable.

Internet-delivered CBT (ICBT)

Therapist-guided internet-delivered CBT for health anxiety has randomized-trial evidence of efficacy comparable to face-to-face treatment (Axelsson and colleagues, JAMA Psychiatry). Highly relevant because health-anxious patients are often dispersed and may avoid in-person care; ICBT improves access and scalability while retaining effectiveness.

SSRIs (fluoxetine, sertraline, escitalopram, paroxetine)

First-line pharmacotherapy with controlled-trial support. The landmark Fallon and colleagues trial demonstrated efficacy of fluoxetine, of CBT, and of their combination for hypochondriasis/health anxiety. SSRIs reduce the anxiety and preoccupation directly. Standard antidepressant onset (4-8 weeks) and duration considerations apply; continue 6-12 months after response.

Combined CBT plus SSRI

For moderate-to-severe or treatment-resistant health anxiety, combining CBT with an SSRI is supported by the Fallon trial and is a reasonable first choice when severity is high. The combination addresses both the cognitive-behavioral maintenance cycle and the underlying anxiety physiology.

Reassurance-reduction and a single coordinated medical home

A practical, evidence-consistent management strategy: consolidate care under one trusted clinician who provides scheduled, predictable visits rather than symptom-triggered ones, and who minimizes repeated low-yield testing. This breaks the doctor-shopping and serial-investigation cycle that reinforces health anxiety, while ensuring genuine new symptoms are still appropriately evaluated.

Mindfulness-based and acceptance approaches

Mindfulness-based cognitive therapy and acceptance and commitment therapy shift the relationship to health-related thoughts (observing them without compulsive response) rather than disputing each feared illness. Useful adjuncts or alternatives for patients who have plateaued in standard CBT-HA or who prefer an acceptance-based framing.

When standard treatments fail

Health anxiety that does not respond to an adequate course of CBT-HA plus an SSRI should prompt reassessment of the formulation: is this actually somatic symptom disorder (prominent real symptoms), OCD with illness-themed obsessions (which may respond to higher-dose SSRI and ERP), or an underlying depression driving the health preoccupation? The escalation pathway: ensure the CBT was specifically health-anxiety-focused and reduced reassurance-seeking (generic supportive therapy is often inadequate) → optimize SSRI dose and duration, or switch SSRI → consider combined CBT plus SSRI if not already used → add or switch to exposure-and-response-prevention if OCD features predominate → treat comorbid depression on its own track. A recurring practical problem is that the patient keeps seeking new medical workups; aligning all involved clinicians on a reassurance-reduction, single-medical-home plan is frequently the step that finally allows the psychological treatment to work.

Where ketamine fits

Ketamine is not a treatment for illness anxiety disorder, and we will not present it as one. There is no trial evidence for ketamine in health anxiety, and the disorder's mechanism — catastrophic misinterpretation of bodily sensations maintained by reassurance-seeking and checking behaviors — is precisely what cognitive-behavioral therapy targets, with SSRIs as the first-line pharmacologic complement. The evidence-based path is CBT-HA (including internet-delivered formats) and SSRIs, alone or combined. Ketamine becomes relevant only in the specific situation where a patient with health anxiety also has a co-occurring, treatment-resistant major depressive disorder (two or more failed adequate antidepressant trials). In that case ketamine targets the depression, while the health anxiety continues to be treated with CBT and SSRIs. Patients should be cautioned that the dissociative phenomenology of a ketamine session can transiently heighten somatic-focused anxiety in health-anxious individuals, which is one more reason ketamine is reserved for clear depression indications rather than the health anxiety itself.

Where this fits with Tovani

Tovani does not treat health anxiety (illness anxiety disorder) as a standalone indication with ketamine — it is not an evidence-based use. Patients whose primary problem is health anxiety are best served by CBT specifically adapted for health anxiety (widely available in internet-delivered formats) and, where appropriate, an SSRI prescribed by their primary care clinician or psychiatrist. Where Tovani is relevant is the patient who also carries a separately diagnosed, treatment-resistant major depressive disorder; eligibility screening evaluates that depression on its own merits, and any ketamine treatment is directed at the depression while the health anxiety is managed with first-line psychological and pharmacologic care. Because the dissociative experience of ketamine can transiently amplify body-focused anxiety, the screening and preparation specifically address this for health-anxious patients.

Frequently asked

Is illness anxiety disorder the same as hypochondria?

It is the modern successor to most of what used to be called hypochondriasis. DSM-5-TR split the old hypochondriasis diagnosis into two: people with prominent real physical symptoms are now diagnosed with somatic symptom disorder, while those with minimal symptoms but a strong, persistent fear of being or becoming seriously ill are diagnosed with illness anxiety disorder. The term "hypochondriasis" is now largely retired in DSM-5-TR, though ICD-11 still uses it.

Why does getting reassurance from my doctor only help for a little while?

Reassurance-seeking is one of the behaviors that actually maintains health anxiety. The relief it provides is brief, and seeking it reinforces the underlying belief that you need external checking to feel safe — so the anxiety returns and the cycle repeats, often escalating. This is why effective treatment deliberately works on reducing reassurance-seeking and repeated testing, while still ensuring genuinely new symptoms get appropriate evaluation.

Can ketamine help my health anxiety?

No — ketamine is not a treatment for health anxiety (illness anxiety disorder), and we will not present it as one. There is no trial evidence for it in this condition, and the disorder responds to cognitive-behavioral therapy adapted for health anxiety plus SSRIs. Ketamine would only be relevant if you separately have a treatment-resistant major depression, in which case it treats the depression, not the health anxiety. The dissociative experience of ketamine can even briefly heighten body-focused anxiety, so it is not directed at the health anxiety itself.

What kind of therapy works for health anxiety?

Cognitive-behavioral therapy specifically adapted for health anxiety (CBT-HA) is first-line and well-supported by randomized trials, including therapist-guided internet-delivered versions that work about as well as in-person sessions. It targets the catastrophic interpretation of normal body sensations, the body-checking and reassurance-seeking cycle, and the selective focus on health threat. Mindfulness- and acceptance-based approaches are reasonable alternatives or add-ons.

How is health anxiety different from OCD?

They overlap, and ICD-11 actually groups hypochondriasis with obsessive-compulsive and related disorders. The practical difference is content and insight: in illness anxiety disorder the worry is exclusively about having or getting a serious disease and the belief is often held with less recognition that it is excessive, whereas OCD spans varied themes with compulsions the person usually recognizes as irrational. Body-checking in health anxiety can look just like an OCD compulsion, and some people meet criteria for both.

References

  1. Fallon BA et al. 2017, American Journal of Psychiatry Randomized controlled trial of medication (fluoxetine) and cognitive-behavioral therapy for hypochondriasis/health anxiety — establishes efficacy of SSRIs, CBT, and their combination as first-line treatments. (PMID 28659038)
  2. Axelsson E et al. 2020, JAMA Psychiatry Randomized trial of internet- versus face-to-face cognitive behavior therapy for severe health anxiety — demonstrates internet-delivered CBT efficacy comparable to in-person treatment, supporting scalable access. (PMID 32401286)
  3. Scarella TM et al. 2019, Psychosomatic Medicine Review of illness anxiety disorder psychopathology, epidemiology, and clinical management — articulates the DSM-5-TR split from hypochondriasis and the distinction from somatic symptom disorder. (PMID 30920464)
  4. Murrough JW et al. 2013, American Journal of Psychiatry Ketamine RCT in treatment-resistant depression — relevant only to a co-occurring treatment-resistant major depressive disorder, not to illness anxiety disorder itself, for which ketamine is not a treatment. (PMID 23982301)

Last reviewed by Dr. Ben Soffer, DO on May 27, 2026. This page is educational and not a substitute for clinical evaluation. A physician determines whether ketamine therapy is appropriate for your specific situation.